CUA Educational Content

Prostate Cancer Screening & ADT Management

FEATURING: Ricardo Rendon

By the end of this program, participation will:

  • gain insight into the rationale for prostate cancer screening
  • review the current recommendations for the management of elevated PSA
  • discuss the adverse side effects of ADT for the treatment of prostate cancer

 

This program has received financial support from Astellas, Bayer and Sanofi in the form of educational grant.

 

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy